[1] Stein CA, Cohen JS. Oligodeoxynucleotides as inhibitors of gene expression: a review [J]. Cancer Res, 1988, 48: 2659-2668. [2] Tamm I, Doerken B, Hartmann G. Antisense therapy in oncology: new hope for an old idea [J]. Lancet, 2001, 358: 489-497. [3] Yang ZJ, Zhang HY, Min JM, et al. Synthesis and enzymatic stability of oligonucleotides consisting of isonucleosides [J]. Pure Appl Chem, 1999, 71: 1143-1146. [4] Yang ZJ, Zhang HY, Min JM, et al. Synthesis and duplex stabilization of oligonucleotides consisting of isonucleosides [J]. Helv Chim Acta, 1999, 82: 2037-2043. [5] Lei Z, Zhang L, Zhang LR, et al. Hybrid characteristics of oligonucleotides consisting of isonucleoside 2’, 5’- anhydro-3’-deoxy-3’-(thymin-1-yl)-D-mannitol with different linkage modes [J]. Nucleic Acids Res, 2001, 29: 1470-1475. [6] Chen J, Zhang LR, Min JM, et al. Studies on the synthesis of a G-rich octaoligoisoncleotide (isoT)2(isoG)4(isoT)2 by the phosphotriester approach and its formation of G-quartet structure. Nucleic Acids Res, 2002, 30: 3005-3014. [7] Yang ZJ, Yu HW, Min JM, et al. Stereoselecive synthesis of 4-deoxy-4-nucleobase-2,5-anhydro-L-mannito derivatives [J]. Tetrahedron Asymmetry, 1997, 8: 2739-2747. |